Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness and safety of ranibizumab in patients with central retinal vein occlusion: results from the real-world, global, LUMINOUS study.
Lotery A, Clemens A, Tuli R, Xu X, Shimura M, Nardi M, Ziemssen F, Dunger-Baldauf C, Tadayoni R; LUMINOUS™ study group. Lotery A, et al. Among authors: dunger baldauf c. Eye (Lond). 2022 Aug;36(8):1656-1661. doi: 10.1038/s41433-021-01702-y. Epub 2021 Jul 29. Eye (Lond). 2022. PMID: 34326500 Free PMC article. Clinical Trial.
Reply.
Holz FG, Figueroa MS, Bandello F, Yang Y, Ohji M, Dai H, Wykrota H, Sharma S, Dunger-Baldauf C, Lacey S, Macfadden W, Mitchell P; all the LUMINOUS study investigators. Holz FG, et al. Among authors: dunger baldauf c. Retina. 2020 Sep;40(9):e51-e53. doi: 10.1097/IAE.0000000000002909. Retina. 2020. PMID: 32842092 No abstract available.
Real-world outcomes with ranibizumab in branch retinal vein occlusion: The prospective, global, LUMINOUS study.
Pearce I, Clemens A, Brent MH, Lu L, Gallego-Pinazo R, Minnella AM, Creuzot-Garcher C, Spital G, Sakamoto T, Dunger-Baldauf C, McAllister IL; all the LUMINOUS™ study investigators. Pearce I, et al. Among authors: dunger baldauf c. PLoS One. 2020 Jun 18;15(6):e0234739. doi: 10.1371/journal.pone.0234739. eCollection 2020. PLoS One. 2020. PMID: 32555630 Free PMC article. Clinical Trial.
Effectiveness and safety of ranibizumab 0.5 mg in treatment-naïve patients with diabetic macular edema: Results from the real-world global LUMINOUS study.
Mitchell P, Sheidow TG, Farah ME, Mahmood S, Minnella AM, Eter N, Eldem B, Al-Dhibi H, Macfadden W, Parikh S, Dunger-Baldauf C, Mahgoub MM, Schmidt-Erfurth U; LUMINOUS study investigators. Mitchell P, et al. Among authors: dunger baldauf c. PLoS One. 2020 Jun 3;15(6):e0233595. doi: 10.1371/journal.pone.0233595. eCollection 2020. PLoS One. 2020. PMID: 32492069 Free PMC article. Clinical Trial.
Real-world effectiveness and safety of ranibizumab for the treatment of myopic choroidal neovascularization: Results from the LUMINOUS study.
Hamilton RD, Clemens A, Minnella AM, Lai TYY, Dai H, Sakamoto T, Gemmy Cheung CM, Ngah NF, Dunger-Baldauf C, Holz FG; LUMINOUS study group. Hamilton RD, et al. Among authors: dunger baldauf c. PLoS One. 2020 Jan 21;15(1):e0227557. doi: 10.1371/journal.pone.0227557. eCollection 2020. PLoS One. 2020. PMID: 31961888 Free PMC article.
24 results